Cell therapy
Oryginalny tytuł ogłoszenia
Spain – Pharmaceutical products – Suministro de medicamentos destinados a diversas terapias avanzadas para el Servicio Canario de la Salud
Ocena szansy
Skąd ta ocena?
Szansa
65 / 100
Złożoność
40 / 100
Czynniki ryzyka
Structured data indicates EU-funded, but XML notice states no EU funds. This could affect eligibility or reporting requ...
Full procurement documents (PCAP, etc.) were not analyzed. Critical details on terms, conditions, and requirements may...
Restricted procedure — pre-qualification required
Głęboka analiza portfolio
Wykorzystuje:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Najważniejsze informacje
- Zamawiający
- Dirección General de Recursos Económicos del Servicio Canario de la Salud
- Kraj
- Hiszpania
- CPV
- 33600000 - Pharmaceutical products +1 więcej
- Termin
- Mar 12, 2030
- Szacowana wartość
- EUR 40M
Przegląd
Strong opportunityKluczowe fakty
- EUR 40M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Supply of advanced therapy medicinal products (cell therapy) for the Canary Health Service.
- Coverage of various and diverse advanced therapies as technology and research evolve.
Pokaż pełne podsumowanie
This tender by the Canary Health Service (Dirección General de Recursos Económicos del Servicio Canario de la Salud) is for the supply of advanced therapy medicinal products (cell therapy) via a Dynamic Purchasing System (DPS) under a restricted procedure. The estimated total value is €40,037,508, with a single lot covering various advanced therapies. The deadline for submission is 2030-03-12, providing a long bidding period. Award is based solely on price (100% weight). The tender is conducted in Spanish and appears EU-funded per structured data, though the XML notice indicates no EU funds. Only the TED XML notice was analyzed; full procurement documents are missing.
Ryzyka
Structured data indicates EU-funded, but XML notice states no EU funds. This could affect eligibility or reporting requ...
Full procurement documents (PCAP, etc.) were not analyzed. Critical details on terms, conditions, and requirements may...
Restricted procedure — pre-qualification required
Analiza może być niepełna
Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.
Kluczowe wymagania
Technical
- Supplies of pharmaceutical products classified under CPV 33600000 and 33690000.
- Contract period from 2025-03-12 to 2030-03-12 (5 years).
Administrative
- Electronic submission required.
Kryteria udzielenia
Lot 1
Zamawiający
Lokalizacja
Las Palmas de Gran Canaria, ESP
Profil zamawiającego
Identyfikator
21058580149618
Działalność
Health
Części (1)
LOT-0000
Cell therapy
Supply of various advanced therapy medicinal products (cell therapy) for the Canary Health Service, covering evolving needs as technology and research advance.
EUR 40M
Szacowana wartość
Lokalizacja
Kategoria
Kryteria udzielenia
Termin
Szczegóły kryteriów
Precio. . Terapia celular.
Dodatkowe kody CPV
Uwaga do wartości
Pokaż oryginalne dane TED
Oryginalny tytuł części
Terapia celular
Oryginalny opis TED
Suministro de medicamentos destinados a diversas y variadas terapias avanzadas
Szczegóły zamówienia
- Data publikacji
- 12 Mar 2025
- Języki
- Spanish
Metadane referencyjne
- Podstawa prawna
- 32014L0024
Identyfikatory referencyjne
- ID przetargu
- 163196-2025
Dokumenty (1)
Podobne przetargi
Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA
Italy – Various medicinal products – Bando V SDA farmaci
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на КОЦ-Русе ЕООД
Italy – Various medicinal products – ARIA_2025_045
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на УМБАЛ "Царица Йоанна-ИСУЛ" ЕАД
Italy – Various medicinal products – Bando SDA Farmaci, Emoderivati, Vaccini e Mezzi di contrasto - Terza edizione
Ocena szansy
Skąd ta ocena?
Szansa
65 / 100
Złożoność
40 / 100
Czynniki ryzyka
Structured data indicates EU-funded, but XML notice states no EU funds. This could affect eligibility or reporting requ...
Full procurement documents (PCAP, etc.) were not analyzed. Critical details on terms, conditions, and requirements may...
Restricted procedure — pre-qualification required
Głęboka analiza portfolio
Wykorzystuje:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications